Nabilone administration in refractory chronic diarrhea: a case series
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nabilone administration in refractory chronic diarrhea: a case series
Authors
Keywords
CB1 receptor, Cannabinoids, Nabilone, Chronic diarrhea, Gastrointestinal disorders, Refractory, Case series
Journal
BMC GASTROENTEROLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-25
DOI
10.1186/s12876-019-1024-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence
- (2018) Marieke Hiemstra et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabinoid pharmacology and therapy in gut disorders
- (2018) J.A. Uranga et al. BIOCHEMICAL PHARMACOLOGY
- Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
- (2018) Tim Ambrose et al. Journal of Crohns & Colitis
- Role of cannabis in digestive disorders
- (2017) Hemant Goyal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Cannabinoids as gastrointestinal anti-inflammatory drugs
- (2017) A. Fabisiak et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
- (2017) Carina Hasenoehrl et al. Expert Review of Gastroenterology & Hepatology
- Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
- (2016) Klára Gyires et al. Current Neuropharmacology
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
- (2016) C. Hasenoehrl et al. NEUROGASTROENTEROLOGY AND MOTILITY
- May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
- (2016) R. Abalo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
- (2014) Martin Storr et al. INFLAMMATORY BOWEL DISEASES
- Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
- (2013) Maciej Sałaga et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
- (2013) Jessica Ravikoff Allegretti et al. INFLAMMATORY BOWEL DISEASES
- Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
- (2012) B. S. Wong et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings
- (2011) A Mallat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis use amongst patients with inflammatory bowel disease
- (2011) Simon Lal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started